Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genome-wide identification, characterisation and expression profiling of the ubiquitin-proteasome genes in Biomphalaria glabrata.
Portilho LG, Duarte BCD, Queiroz FR, Ribeiro THC, Jeremias WJ, Babá EH, Coelho PMZ, Morais ER, Cabral FJ, Caldeira RL, Gomes MS. Portilho LG, et al. Among authors: jeremias wj. Mem Inst Oswaldo Cruz. 2019;114:e190052. doi: 10.1590/0074-02760190052. Epub 2019 Jun 3. Mem Inst Oswaldo Cruz. 2019. PMID: 31166481 Free PMC article.
Serological proteomic screening and evaluation of a recombinant egg antigen for the diagnosis of low-intensity Schistosoma mansoni infections in endemic area in Brazil.
Silva-Moraes V, Shollenberger LM, Castro-Borges W, Rabello ALT, Harn DA, Medeiros LCS, Jeremias WJ, Siqueira LMV, Pereira CSS, Pedrosa MLC, Almeida NBF, Almeida A, Lambertucci JR, Carneiro NFF, Coelho PMZ, Grenfell RFQ. Silva-Moraes V, et al. Among authors: jeremias wj. PLoS Negl Trop Dis. 2019 Mar 14;13(3):e0006974. doi: 10.1371/journal.pntd.0006974. eCollection 2019 Mar. PLoS Negl Trop Dis. 2019. PMID: 30870412 Free PMC article.
Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 Study.
Grenfell RFQ, Almeida NBF, Filgueiras PS, Corsini CA, Gomes SVC, de Miranda DAP, Lourenço AJ, Martins-Filho OA, de Oliveira JG, Teixeira-Carvalho A, Campos GRF, Nogueira ML, Alves PA, Fernandes GR, Castilho LR, Lima TM, de Abreu DPB, Alvim RGF, Silva TBS, Jeremias WJ, Otta DA, Campi-Azevedo AC; Immunita-001 Team. Grenfell RFQ, et al. Among authors: jeremias wj. Front Immunol. 2022 Jun 9;13:918896. doi: 10.3389/fimmu.2022.918896. eCollection 2022. Front Immunol. 2022. PMID: 35757764 Free PMC article. Clinical Trial.
Rapid antigen test as a tool for the identification of SARS-CoV-2 infection and its potential as a self-testing device.
Filgueiras PS, Corsini CA, Almeida NBF, Pedrosa MLC, Miranda DAP, Gomes SVC, Assis JV, Silva RA, Medeiros MIVARC, Lourenço AJ, Bicalho CMF, Vilela RVR, Jeremias WJ, Fernandes GDR, Queiroz RFGE. Filgueiras PS, et al. Among authors: jeremias wj. Rev Soc Bras Med Trop. 2023 May 22;56:e01672022. doi: 10.1590/0037-8682-0167-2022. eCollection 2023. Rev Soc Bras Med Trop. 2023. PMID: 37222349 Free PMC article.
Immunogenicity and safety of inactivated SARS-CoV-2 vaccine (CoronaVac) using two-dose primary protocol in children and adolescents (Immunita-002, Brazil): A phase IV six-month follow up.
Corsini CA, Martins PFDS, Filgueiras PS, Lourenço AJ, Lima AES, Gomes SVC, Jeremias WJ, Alves PA, Fernandes GDR, Castro LLME, de Carvalho AT, Azevedo ACC, Curimbaba CAL, Lorencini DA, Junior EM, da Silva VM, Cervi MC, Borges MC, Nogueira ML, Campos GRF, Correa PRL, Carvalho TML, Dos Reis JGAC, Reis EVS, Castilho LDR, de Lima PR, do Nascimento JPR, de Oliveira JG, Filho OAM, Grenfell RFQE; Immunita team. Corsini CA, et al. Among authors: jeremias wj. Res Sq [Preprint]. 2024 Feb 29:rs.3.rs-3931021. doi: 10.21203/rs.3.rs-3931021/v1. Res Sq. 2024. PMID: 38464059 Free PMC article. Preprint.